The expression of iNOS, COX-2, IL-1β, TNF-α and IL-6 in liver could be decreased by the treatment of APS or EAPS (p < 0.01 or p < 0.05) as compared to that in the MC group (Fig. 7B–F). Here, IL6 is linked to autoimmune polyendocrinopathy.